Quinn Opportunity Partners’s Genocea Biosciences, Inc. GNCA Stock Holding History

Quinn Opportunity Partners’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,000	Closed	-$9K	–	215
2019 Q1	$9K	Hold	2,000	–	–	﹤0.01%	183
2018 Q4	$5K	Sell	2,000 -888	-31%	-$4.42K	﹤0.01%	168
2018 Q3	$18K	Sell	2,888 -11,250	-80%	-$59.4K	﹤0.01%	184
2018 Q2	$97K	Hold	14,138	–	–	0.01%	183
2018 Q1	$119K	Hold	14,138	–	–	0.02%	188
2017 Q4	$131K	Sell	14,138 -1,250	-8%	-$12.6K	0.02%	166
2017 Q3	$180K	Buy	+15,388	New	+$584K	0.03%	199

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Quinn Opportunity Partners's GNCA Position: Q2 2019 in Review

Quinn Opportunity Partners sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2019, closing a stake of 2,000 shares — an estimated $9K sold.

Quinn Opportunity Partners first reported a position in GNCA in Q3 2017 and held it in 7 quarters. The position peaked at $180K in Q3 2017. 45 funds tracked by Wall St. Rank hold GNCA as of Q2 2019.

Quinn Opportunity Partners reported no remaining Genocea Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
Quinn Opportunity Partners sold 2,000 Genocea Biosciences, Inc. shares in Q2 2019, an estimated $9K.
Quinn Opportunity Partners first reported a position in Genocea Biosciences, Inc. in Q3 2017 and held it in 7 quarters.
Quinn Opportunity Partners's Genocea Biosciences, Inc. position peaked at $180K in Q3 2017.
45 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2019.

Based on Quinn Opportunity Partners's 13F filing for Q2 2019, filed 9 Aug 2019.